2.8. Ethical Considerations
The study was approved by the Salamanca Health Area Clinical Research Ethics Committee (CEIm Code: PI 2020 10 578). The participants, before the start of the study, were informed of the objectives of the project and the risks and benefits of the explorations. Subsequently, they signed the informed consent in accordance with the Declaration of Helsinki [All the data collected in the study have been processed following the regulations in force in Spanish territory regarding the protection of data in biomedical research: Organic Law 3/2018 on the protection of personal data, Law 14/2007 on biomedical research, and European Regulation 2016/679 of data protection.